bioRxiv Science⌕ Search

Biology subjects

Bertin, P.

Publications and source records attributed to Bertin, P..

2 recordsLinked to original sources

Hidden sampling biases inflate performance in gene regulatory network inference

Accurate reconstruction of gene regulatory networks (GRNs) from single-cell transcriptomic data remains a major methodological challenge. Recent machine learning approaches, particularly graph neural networks and graph autoencoders, have reported improved performance, yet these gains do not consistently translate to realistic biological settings. Here, we show that a key reason for that is the way negative regulatory interactions are sampled for supervised training and evaluation. We find that widely used sampling strategies introduce node-degree biases that allow models to exploit trivial graph-structural cues rather than biological signals. Across multiple benchmarks, simple degree-based heuristics match or exceed state-of-the-art graph neural network models under these biased evaluation protocols. We further introduce a degree-aware sampling approach that eliminates these artifacts and provides more reliable assessments of GRN inference methods. Our results call for standardized, bias-aware benchmarking practices to ensure meaningful progress in supervised GRN inference from single-cell RNA-seq data.

bioinformatics↗

Heterobifunctional proteomimetic polymers for targeted protein degradation

The burgeoning field of targeted protein degradation (TPD) has opened new avenues for modulating the activity of previously undruggable proteins of interest. To date, TPD has been dominated by small molecules containing separate linked domains for protein engagement and recruitment of cellular degradation machinery. The process of identifying active compounds has required tedious optimization and has been successful largely against a limited set of targets with well-defined, suitable docking pockets. Here we present a polymer chemistry approach termed the HYbrid DegRAding Copolymer (HYDRAC) to overcome standing challenges associated with the development of TPD. These copolymers densely display either peptide-based or small molecule-derived degradation inducers and target-binding peptide sequences for the selective degradation of disease-associated proteins. HYDRACs are synthesized in a facile manner, are modular in design, and are highly selective. Using the intrinsically disordered transcription factor MYC as an initial proof-of-concept, difficult to drug protein target, HYDRACs containing a MYC-inhibitory peptide copolymerized with a validated degron, showed robust and selective degradation of the target protein. Treatment of tumor-bearing mice with MYC-targeted HYDRACs showed decreased cell proliferation and increased tumor apoptosis, leading to significantly suppressed tumor growth in vivo. The versatility of the platform was demonstrated by substituting the degron for recruiters of three different E3 ligases (VHL, KEAP1, and CRBN), which all maintained MYC degradation. To demonstrate generalizability, HYDRACs were further designed against a second elusive target of clinical interest, KRAS, by employing a consensus RAS binding motif. RAS-targeted HYDRACs showed degradation in two cell lines harboring separate KRAS alleles, suggesting potential pan-KRAS activity. We envision the HYDRAC platform as a generalizable approach to developing degraders of proteins of interest, greatly expanding the therapeutic armamentarium for TPD.

bioengineering↗